BY MELISSA QUINN
The Biden administration on Sunday appeared to dismiss suggestions from some congressional Democrats that it ignore a ruling from a federal judge in Texas that took aim at the abortion pill, with a spokeswoman saying doing so would set a “dangerous precedent.”
In a series of tweets in response to a decision from U.S. District Judge Matthew Kacsmaryk halting the Food and Drug Administration’s (FDA) approval of the drug mifepristone, Kamara Jones, spokeswoman for the Department of Health and Human Services, reiterated that the agency is prepared to continue defending that 22-year-old approval through the legal process.
“People are rightly frustrated about this decision — but as dangerous a precedent it sets for a court to disregard FDA’s expert judgment regarding a drug’s safety and efficacy, it would also set a dangerous precedent for the administration to disregard a binding decision,” Jones said. “We are confident that the law is on our side.”
